JP Morgan Chase
MED icon

JP Morgan Chase’s Medifast MED Stock Holding History

JP Morgan Chase’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-311,600
Closed -$43.2M – 5650
2020
Q2 		$43.2M Buy
+311,600
New +$28.6M 0.01% 956
2020
Q1 		– Sell
-11,100
Closed -$1.22M – 5551
2019
Q4 		$1.22M Buy
+11,100
New +$1.07M ﹤0.01% 3714

Other funds holding MED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SCP
Steamboat Capital Partners Rye, New York $403M AUM 43.57% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return

JP Morgan Chase's MED Position: Q1 2026 in Review

JP Morgan Chase increased its Medifast (MED) stake by 60% in Q1 2026, buying an estimated $354K and bringing the position to 87,178 shares worth $871K. The position accounts for ﹤0.01% of the portfolio, ranked #4695.

JP Morgan Chase first reported a position in MED in Q2 2013 and has held it in 52 quarters since. The position peaked at $17.3M in Q1 2023. 111 funds tracked by Wall St. Rank hold MED as of Q1 2026.

  • JP Morgan Chase held 87,178 shares of Medifast worth $871K as of Q1 2026.
  • JP Morgan Chase bought 32,798 Medifast shares in Q1 2026, an estimated $354K.
  • Medifast made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #4695 holding.
  • JP Morgan Chase first reported a position in Medifast in Q2 2013 and has held it in 52 quarters since.
  • JP Morgan Chase's Medifast position peaked at $17.3M in Q1 2023.
  • 111 funds tracked by Wall St. Rank held Medifast as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.